Prime Therapeutics

Mostafa Kamal to succeed Ken Paulus as Prime Therapeutics’ President and Chief Executive Officer

Press Release July 4, 2023 Featured, People

Paulus to retire after a storied career in health care (Eagan, MN) — July 3, 2023 — Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, today announced that Mostafa Kamal will succeed Ken Paulus as President and CEO of Prime Therapeutics. Kamal currently serves as president of Prime Therapeutics, and the CEO of Magellan Rx, a Prime Therapeutics company. His new role elevates him to include

Business

Prime Therapeutics’ Intervention Pilot for Opioid Users Improves Outcomes

Press Release July 21, 2022 Business

Opioid registry, predictive modeling help identify at-risk Medicare members in Florida (Eagan, MN) — July 18, 2022 — During the COVID-19 pandemic, drug overdoses killed over 107,000 Americans in 2021.1 Prior to the pandemic, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members nationally, began an intervention program targeting Medicare members who were at high risk of overutilizing opioids. A pilot with Medicare members of GuideWell